Risk adjustment using administrative and clinical data: model comparison

Slides:



Advertisements
Similar presentations
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction Robert W. Yeh, MD MSc Massachusetts General Hospital Alan S. Go, MD Kaiser.
Advertisements

Does Preoperative Hemoglobin Value Predict Postoperative Cardiovascular Complications after Total Joint Arthroplasty? Kishor Gandhi MD, MPH, Eugene Viscusi.
12 June 2004Clinical algorithms in public health1 Seminar on “Intelligent data analysis and data mining – Application in medicine” Research on poisonings.
The Influence of Radial vs. Femoral Access on Acute Blood Loss in Patients Undergoing Percutaneous Coronary Intervention Amit Nanda 1, Eric Novak MS 2,
Inappropriate clopidogrel adherence explains stent related adverse outcomes Leonardo Tamariz, MD, MPH University of Miami.
Primary care of hypertensive patients and the risk of acute events Irina Stirbu-Wagner Markus MJ Nielen Maaike Langelaan Robert A. Verheij Joke C. Korevaar.
RACIAL DISPARITIES IN PRESCRIPTION DRUG UTILIZATION AN ANALYSIS OF BETA-BLOCKER AND STATIN USE FOLLOWING HOSPITALIZATION FOR ACUTE MYOCARDIAL INFARCTION.
1 Canadian Institute for Health Information. Hospital Care for Heart Attacks Among First Nations, Inuit and Métis Released January 31,
Sample size calculation
Hemoglobin A 1c in Hemodialysis Patients Source: Ix JH. Hemoglobin A1c in hemodialysis patients: Should one size fit all? Clin J Am Soc Nephrol. 2010;5:1539–1541.
Clinical Impact of Adherence to Pharmacotherapeutic Guidelines on the Outcome in Patients with Chronic Heart Failure Suntheep Batra, M.Pharm Department.
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
Validation of Mayo Clinic Risk Adjustment Model for In-Hospital Mortality following Percutaneous Coronary Interventions using the National Cardiovascular.
Complete Recovery of Renal Function After Acute Kidney Injury is Associated with Long-Term All-Cause Mortality In a Large Managed Care Organization Jennifer.
Modeling Risk Adjusted Capitation Rates in Regione Umbria Elaine Yuen, PhD; Daniel Z. Louis, MS; Paolo DiLoreto; Joseph S. Gonnella, MD American Public.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar Dr.PH. Batch 5 1.
Surgeon Specialty and Operative Mortality With Lung Resection PP Goodney, FL Lucas, TS Stukel, JD Birkmeyer VA Outcomes Group, White River Junction, VT.
The EuroHOPE- project: Comparison of treatment and outcome for AMI and stroke patients in Europe On behalf of the EuroHOPE-team: Terje P. Hagen Department.
Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,
Monthly Journal article review: Vimmi Kang PGY 2
IMPACT OF DISPARITIES IN CARDIOVASCULAR CARE ON AFRICAN AMERICAN DEATHS Kevin Fiscella, MD, MPH University of Rochester School of Medicine & Dentistry.
Developments & Issues in the Production of the Summary Hospital-level Mortality Indicator (SHMI) Health and Social Care Information Centre (HSCIC)
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar DrPH Batch 5 1.
Applying meta-analysis to trauma registry Ammarin Thakkinstian, Ph.D. Clinical Epidemiology Unit Faculty of Medicine, Ramathibodi Hospital Tel: ,
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
© 2003 By Default! A Free sample background from Slide 1 PCI Risk Model Comparisons An alternative model for case level estimation.
Evaluating Risk Adjustment Models Andy Bindman MD Department of Medicine, Epidemiology and Biostatistics.
Wins/Losses and Errors/Ties: Quality of Care for Acute Myocardial Infarction in the VA Health Care System Laura A. Petersen, M.D., M.P.H. 1 Sharon-Lise.
A Claims Database Approach to Evaluating Cardiovascular Safety of ADHD Medications A. J. Allen, M.D., Ph.D. Child Psychiatrist, Pharmacologist Global Medical.
1 EPI235: Epi Methods in HSR April 5, 2005 L3 Evaluating Health Services using administrative data 2: Advanced Topics in Risk Adjustment (Dr. Schneeweiss)
Handbook for Health Care Research, Second Edition Chapter 13 © 2010 Jones and Bartlett Publishers, LLC CHAPTER 13 Statistical Methods for Continuous Measures.
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
Is Veteran User Status an Independent Risk Factor for Mortality After Private Sector CABG? William B. Weeks, MD, MBA Dorothy A. Bazos, Ph.D. David M. Bott,
Health Care Market Structure, Safety Net Hospitals, and the Quality of Hospital Care José J. Escarce, MD, PhD David Geffen School of Medicine at UCLA and.
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
Re-fracture risk in older patients prescribed bisphosphonates Chiara Sorge Rome, 15th October 2012.
Building a framework for integrated use of health information system and clinical data in epidemiology R. Di Domenicantonio Workshop Challenges for epidemiology.
Evaluating health outcomes: the experience of a national evaluation programme Luigi Pinnarelli Rome, 15-16/10/2012.
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
How can we use geographic variation in unplanned admissions to improve efficiency? John Busby CLAHRC West.
Matching methods for estimating causal effects Danilo Fusco Rome, October 15, 2012.
Bootstrap and Model Validation
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.
Landon Marshall, Pharm. D. , Matt Hill, Pharm. D. , Jim Wilson, Pharm
135th Annual Meeting of APHA, November 3-7, 2007 Washington DC Session
Jan B. Pietzsch1, Benjamin P. Geisler1, Murray D. Esler 2
Lynn Josephs, David Culliford, Matthew Johnson, Mike Thomas
David Culliford, Lynn Josephs, Matthew Johnson, Mike Thomas
Evaluating Policies in Cardiovascular Medicine
ASPIRE Workshop 5: Application of Biostatistics
Improving Chronic Care Management
ASPIRE Workshop 5: Application of Biostatistics
S1316 analysis details Garnet Anderson Katie Arnold
INDIRECT STANDARDIZATION BY MBBSPPT.COM
Patterns of Use of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Among Patients With Acute Myocardial Infarction in China From.
Annals of Internal Medicine • Vol. 167 No. 12 • 19 December 2017
Fibrinolytic therapy in hospitals without percutaneous coronary intervention capabilities in China from 2001 to 2011: China PEACE-retrospective AMI study.
Date: Presenter: Ryan Chen
Monthly Journal article review: Vimmi Kang PGY 2
Antiplatelet Therapy Use after Discharge among Acute Myocardial Infarction Patients with In-hospital Bleeding Tracy Y. Wang, MD, MHS, Lan Xiao, PhD, Karen.
No Financial Disclosure or Conflict of Interest
Patient characteristics associated with inpatient mortality within 1 year after hip fracture surgery (multivariable logistic regression model adjusted.
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.
EPIDEMIOLOGY AS A TOOL TO EVALUATE QUALITY OF CARE
ASPIRE Workshop 5: Application of Biostatistics
Urban–Rural Comparisons in Hospital Admission, Treatments, and Outcomes for ST-Segment–Elevation Myocardial Infarction in China From 2001 to 2011 A Retrospective.
Admission Glucose and In-hospital Mortality after Acute Myocardial Infarction in Patients with or without Diabetes: A Cross-sectional Study Shi Zhao, Karthik.
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
Effect Modifiers.
Presentation transcript:

Risk adjustment using administrative and clinical data: model comparison Paola Colais Workshop “Challenges for epidemiology in the context of the National Health Service” Rome, October 15th – 16th, 2012

Background The assessment of hospital care quality has become increasingly important in many European countries, and worldwide, in response to requests for greater transparency and accountability and for quality improvement. However, observational studies comparing groups or populations to evaluate services or interventions strongly require severity and comorbidity adjustment to account for differences between the groups being compared. Little is known about the relative performance of available information systems in predicting outcomes and control for confounding.

Objective To compare the performance of diagnosis, drug prescription and “RAD-esito”-based models in predicting outcomes and control for confounding in hospital quality of care comparative analysis.

Data sources Data sources are: Hospital Information System pharmacy dispensing database RAD-esito (AMI, CABG, Hip Fracture)

Study population Hospital discharges in Lazio region between January 2010 and November 2010 with a diagnosis of Acute Myocardial Infarction (AMI) Hip Fracture

Outcomes Thirty-days mortality from hospital admission was evaluated for AMI patients Proportion of interventions performed within 48 hours from admission was evaluated for hip fracture patients

Methods (1) A multivariate regression analysis was used to calculate adjusted hospital-specific risks using diagnosis, drug prescription and RAD-esito-based predictive models, both separately and jointly. Factors associated with the outcomes were selected by a bootstrap stepwise procedure to assign an importance rank for predictors in logistic regression

Methods (2) Performances were measured by using the ‘c’ statistic, ranging from 0.5 for chance prediction of outcome to 1.0 for perfect prediction. change-in-estimate methods were applied to improve parsimony and gain estimates’ precision, by eliminating variables that are not actual confounders.

Results Hip Fracture (1) INR International Normalized Ratio valuta la capacità del sangue di coagulare c statistic: 0.555 c statistic: 0.573 c statistic: 0.576

Results Hip Fracture (2) Adjusted proportion of interventions performed within 48 hours by hospitals

Results Hip Fracture (3) Adjusted proportion of interventions performed within 48 hours by hospitals

Results Hip Fracture (4) Adjusted proportion of interventions performed within 48 hours by hospitals

Results AMI (1) c statistic: 0.761 c statistic: 0.793

Results AMI (2) Adjusted 30-days mortality after AMI by hospitals

Results AMI (3) Adjusted 30-days mortality after AMI by hospitals

Results AMI (4) Adjusted 30-days mortality after AMI by hospitals

Results Change-in-estimate methods Hospital Information System Hip Fracture No actual confounders AMI Age Blood pressure Diuretics Hospital Information System “RAD-esito” system drug prescription

Critical aspects The use of routinely collected administrative data in comparative outcome evaluations presents some limitations: different coding practices across hospitals and misclassification of comorbidity; absence of some clinical information needed to adjust for patients’ conditions; some chronic comorbidities, such as hypertension and diabetes, are known to be currently under-reported at admission, mainly in more severely affected patients. Hypertension, anemia, not controlled diabetes

Conclusions Hip fracture no differences were found using risk adjustment models with different information systems because there are no factors that are actual confounders. AMI small differences. Some actual confounders from the three different information systems were found.